Detection and quantification of extracellular microRNAs in medulloblastoma

Abstract

Aim: Medulloblastoma (MB) is the most common malignant brain tumor in children. The crucial role of extracellular-microRNAs (ex-miRNAs) in cancer has been widely recognized; however, their role in MB remains unknown. This study aimed to investigate MB-driven ex-miRNAs.

Methods: Microarray analysis was used to disclose the identity and quantity of key miRNAs excreted in culture-medium (CM) of 3 human MB cell lines and cerebrospinal fluid (CSF) of brain tumors (including MB) and leukemia patients. MiRNA expression was validated by quantitative reverse transcription polymerase chain reaction.

Results: We have demonstrated that the 3 MB cell lines tested commonly expressed 1,083 miRNAs in their spent CM. Among them, 57 miRNAs were specific to the CM of metastasis-related cell lines which represents the aggressive group 3 and group 4 MB subtypes. A significant number (1,254) of ex-miRNAs were identified in the CSF of a MB patient. Eighty-six of these miRNAs were found to be differentially expressed in this patient’s CSF compared with controls. Interestingly, 3 metastasis-associated miRNAs over-represented in CM of metastasis-related MB cell lines were found to be significantly enriched in the CSF of the MB patient.

Conclusion: Although more samples are required to fully verify these results, our work provides the first evidence for the presence of a significant amount of miRNAs excreted extracellularly by MB cells and raises the possibility that, in the near future, miRNAs could be probed in CSF of MB patients and serve as novel biological markers.

Keywords

Medulloblastoma / extracellular-microRNA / pediatric cancer

References

[1] Gurney JG,Bunin GR.Ries LA,Gurney JG,Tamra T,Bunin GR.CNS and miscellaneous intracranial and intraspinal neoplasms.Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-19951999;BethesdaNational Institutes of Health51-63

[2] Louis DN,Wiestler OD,Burger PC,Scheithauer BW.The 2007 WHO Classification of Tumours of the Central Nervous System..Acta Neuropathol2007;114:97-109 PMCID:PMC1929165

[3] Tran N,Zhang X,Thomson JM,Rose B.MicroRNA expression profiles in head and neck cancer cell lines..Biochem Biophys Res Commun2007;358:12-7

[4] Calin GA.Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genes..Blood2009;114:4761-70 PMCID:PMC2786287

[5] He H,Li W,Nagy R,Calin GA,Franssila K,Kloos RT,de la Chapelle A.The role of microRNA genes in papillary thyroid carcinoma..Proc Natl Acad Sci U S A2005;102:19075-80 PMCID:PMC1323209

[6] Si ML,Wu H,Wu F.MiR-21-mediated tumor growth..Oncogene2007;26:2799-803

[7] Alsidawi S,Driscoll JJ.MicroRNAs in brain metastases: potential role as diagnostics and therapeutics..Int J Mol Sci2014;15:10508-26 PMCID:PMC4100165

[8] Kosaka N,Ochiya T.Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis..Cancer Sci2010;101:2087-92

[9] Chen X,Zhang J,Zhang CY.Secreted microRNAs: a new form of intercellular communication..Trends Cell Biol2012;22:125-32

[10] Liang H,Zhang S,Zen K.The origin, function, and diagnostic potential of extracellular microRNAs in human body fluids..Wiley Interdiscip Rev RNA2014;5:285-300

[11] Lawrie CH,Dunlop HM,Liggins AP,Banham AH,Boultwood J,Hatton CS.Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma..Br J Haematol2008;141:672-5

[12] Tanaka M,Takanashi M,Ohyashiki J,Kuroda M.Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients..PLoS One2009;4:e5532

[13] Huang Z,Ni S,Sheng W.Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer..Int J Cancer2010;127:118-26

[14] Heneghan HM,Lowery AJ,Newell J.Circulating microRNAs as novel minimally invasive biomarkers for breast cancer..Ann Surg2010;251:499-505

[15] Brase JC,Schlomm T,Haese A,Beissbarth T,Sültmann H.Circulating miRNAs are correlated with tumor progression in prostate cancer..Int J Cancer2011;128:608-16

[16] Resnick KE,Hagan JP,Croce CM.The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform..Gynecol Oncol2009;112:55-9

[17] Wang J,Chang P,Li D,Frazier ML,Sen S.MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease..Cancer Prev Res (Phila).2009;2:807-13 PMCID:PMC5859193

[18] Tsujiura M,Komatsu S,Takeshita H,Konishi H,Deguchi K,Okamoto K.Circulating microRNAs in plasma of patients with gastric cancers..Br J Cancer2010;102:1174-9 PMCID:PMC2853097

[19] Hu Z,Zhao Y,Jin G,Chen Y,Zen K,Shen H.Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer..J Clin Oncol2010;28:1721-6

[20] Baraniskin A,Schlegel U,Zöllner H,Hahn S.Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma..Neuro Oncol2012;14:29-33 PMCID:PMC3245991

[21] Akers JC,Kim R,Nakano I,Kalinina J,Kesari S,Breakefield XO,Van Meir EG,Chen CC.MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development..PLoS One2013;8:e78115

[22] Teplyuk NM,Gabriely G,Kim E,Kim RY,Pastorino S,Krichevsky AM.MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity..Neuro Oncol2012;14:689-700 PMCID:PMC3367845

[23] von Bueren AO,Rajtarova J,Eberhart CG,Arcaro A.Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells..BMC Cancer2007;7:19 PMCID:PMC1794252

[24] Kosaka N,Yoshioka Y,Matsuki Y.Secretory mechanisms and intercellular transfer of microRNAs in living cells..J Biol Chem2010;285:17442-52 PMCID:PMC2878508

[25] Lukiw WJ,Zhao Y,Bhattacharjee S.Spreading of Alzheimer's disease inflammatory signaling through soluble micro-RNA..Neuroreport2012;23:621-6

[26] Turchinovich A,Langheinz A.Characterization of extracellular circulating microRNA..Nucleic Acids Res2011;39:7223-33 PMCID:PMC3167594

[27] Snuderl M,Kirkpatrick ND,Riedemann L,Anolik R,Martin JD,Knevels E,Farrar CT,Mohan N,Roberge S,Bais C,Yip S,Rossig C,Ferrara N,Duda DG,Xu L,Jain RK.Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma..Cell2013;152:1065-76 PMCID:PMC3587980

[28] Cortez MA,Ferdin J,Sood AK.MicroRNAs in body fluids - the mix of hormones and biomarkers..Nat Rev Clin Oncol2011;8:467-77 PMCID:PMC3423224

[29] Hannafon BN.Intercellular Communication by Exosome-Derived microRNAs in Cancer..Int J Mol Sci2013;14:14240-69 PMCID:PMC3742242

[30] Wang J,Liu SM.Tumor-associated circulating microRNAs as biomarkers of cancer..Molecules2014;19:1912-38

[31] Mittelbrunn M.Intercellular communication: diverse structures for exchange of genetic information..Nat Rev Mol Cell Biol2012;13:328-35 PMCID:PMC3738855

[32] Frampton AE,Kazemier G.Serum miR-1290 as a marker of pancreatic cancer - letter..Clin Cancer Res2013;19:5250-1

[33] Hammond J,Varas R.A qualitative comparison of paper flowsheets vs a computer-based clinical information system..Chest1991;99:155-7

[34] Huang X,Liang M,Xia S,Wang D,Costello BA,Tan W,Bevan GH,Sun Z,Wang T,Boardman L,Wang L.Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer..Eur Urol2015;67:33-41 PMCID:PMC4252606

[35] Korzeniewski N,Pahernik S,Hohenfellner M.Identification of cell-free microRNAs in the urine of patients with prostate cancer..Urol Oncol2015;33:16.e17-22

[36] Le MT,Shyh-Chang N,Zhou B,Lodish HF.MicroRNA-125b is a novel negative regulator of p53..Genes Dev2009;23:862-76 PMCID:PMC2666337

[37] Sand M,Sand D,Hahn SA,Altmeyer P.Expression of microRNAs in basal cell carcinoma..Br J Dermatol2012;167:847-55

[38] Sun X,Tai X,Ji W.MicroRNA expression and its detection in human supraglottic laryngeal squamous cell carcinoma..Biomed Rep2013;1:743-746 PMCID:PMC3917082

[39] Sun YM,Chen YQ.Diverse functions of miR-125 family in different cell contexts..J Hematol Oncol2013;6:6 PMCID:PMC3566921

[40] Tang F,He Y,Guo L.MicroRNA-125b induces metastasis by targeting STARD13 in MCF-7 and MDA-MB-231 breast cancer cells..PLoS One2012;7:e35435

[41] Wang H,Dong L,Li K,Luo H.Circulating MiR-125b as a marker predicting chemoresistance in breast cancer..PLoS One2012;7:e34210

[42] Cheng HH,Kroh EM,Chéry L,Nelson PS,Knudsen BS,Pienta KJ,Tewari M.Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia..PLoS One2013;8:e69239

[43] Kosaka N,Hagiwara K,Takeshita F.Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis..J Biol Chem2013;288:10849-59 PMCID:PMC3624465

[44] Zhang Y,Wang XF.Microenvironmental regulation of cancer metastasis by miRNAs..Trends Cell Biol2014;24:153-60 PMCID:PMC3943699

[45] Salido-Guadarrama I,Peralta-Zaragoza O,Rodríguez-Dorantes M.MicroRNAs transported by exosomes in body fluids as mediators of intercellular communication in cancer..Onco Targets Ther2014;7:1327-38